Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Flourishing for Peace

15 novembre 2026 aggiornato da: Universidad del Sinú - Elías Bechara Zainúm

Flourishing for Peace Curriculum (Currículo de Florecimiento Para la Paz)

This study is a six-arm individually randomized group-treated (IRGT) trial comparing five16-week standalone flourishing curricula conditions with a control condition consisting of the regular curriculum. Participants will be individually randomized to one of the six conditions. Self-report variables and heart rate variability (HRV) data will be assessed at four time points: T1 (baseline, before the curriculum begins), T2 (8-week midterm), T3 (16-week, at the end of the curriculum), and T4 (beginning of next term), with the main outcome testing changes between T1 and T3. Primary outcomes include the lnRMSSD as a measure of HRV and the overall self-reported flourishing score. Secondary outcomes include 20 domain specific psychological scales and two other HRV measures (SDNN, and mean heart rate). Course-specific knowledge tests will also be administered to gauge participant engagement and course effectiveness. Study results will be reported in accordance with the Consolidated Standards of Reporting Trials (CONSORT) guidelines for non-pharmacological interventions.

Panoramica dello studio

Tipo di studio

Interventistico

Iscrizione (Stimato)

1050

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • (a) enrollment as a university student at UniSinu; (b) intention to remain in the campus area for at least 12 months and express a commitment to try to remain engaged in the study from beginning to end; and (c) ability to read, speak, and understand Spanish.

Exclusion Criteria:

  • No

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Scienza basilare
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Triplicare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Resilience and Self-Control

This flourishing curriculum is delivered as a stand-alone, 16-week classroom seminar incorporating lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts.

Resilience and Self-Control

Sperimentale: Stress, Coping, and Forgiveness

This flourishing curriculum is delivered as a stand-alone, 16-week classroom seminar incorporating lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts.

Stress, Coping, and Forgiveness

Sperimentale: Mindfulness and Meaning and Purpose

This flourishing curriculum combines two courses, and is delivered as a stand-alone, 16-week classroom seminar. Mindfulness will be taught in 8 of the 16 weeks and Meaning and Purpose will be taught in another 8 weeks. Contents incorporate lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts.

Mindfulness and Meaning and Purpose

Sperimentale: Quality of Relationships for Peace and Positive Emotions

This flourishing curriculum combines two courses, and is delivered as a stand-alone, 16-week classroom seminar. Quality of Relationships for Peace will be taught in 8 of the 16 weeks and Positive Emotions will be taught in another 8 weeks. Contents incorporate lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts.

Quality of Relationships for Peace and Positive Emotions

Sperimentale: Emotional Intelligence, Forgiveness, and Spirituality

This flourishing curriculum is delivered as a stand-alone, 16-week classroom seminar incorporating lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts.

Emotional Intelligence, Forgiveness, and Spirituality

Comparatore attivo: Regular course

Participants assigned to the control condition will continue with their regular university coursework but complete the same measures as the intervention conditions.

Regular course

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Overall Flourishing: Flourish Measure
Lasso di tempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Use the total score across 10 items of the Flourish measure developed by Tyler VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
lnRMSSD
Lasso di tempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Heart rate variability (HRV) will be collected using a validated chest-strap sensor ( the Polar H10; Polar Electro, Kempele, Finland) during standardized resting assessments. The natural logarithm of the root mean square of successive differences between normal RR intervals (lnRMSSD), a time-domain measure of short-term heart rate variability and vagal/parasympathetic regulation, will be used as the primary HRV outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Happiness and Life Satisfaction: subscale of Flourish Measure
Lasso di tempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Mental and Physical Health: subscale of Flourish Measure
Lasso di tempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Meaning and Purpose: subscale of Flourish Measure
Lasso di tempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Character and Virtue: subscale of Flourish Measure
Lasso di tempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Close Social Relationships: subscale of Flourish Measure
Lasso di tempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Depression symptoms: Patient Health Questionnaire-9 (PHQ-9)
Lasso di tempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 0 to 3. Higher score indicates more severe depressive symptoms.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Anxiety Symptoms: Generalized Anxiety Disorder-7 (GAD-7)
Lasso di tempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 0 to 3. Higher scores more severe anxiety symptoms.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
The Short Stress Overload Scale
Lasso di tempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher stress.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Coherence: subscale of the Three Dimensional Meaning in Life Scale (3DM)
Lasso di tempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 7. Higher score indicates higher meaning.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Purpose: subscale of the Three Dimensional Meaning in Life Scale (3DM)
Lasso di tempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 7. Higher score indicates higher meaning.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Significance: subscale of the Three Dimensional Meaning in Life Scale (3DM)
Lasso di tempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 7. Higher score indicates higher meaning.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Trait Forgivingness Scale
Lasso di tempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher forgiveness.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Trait Humility: subscale of Relational Humility Scale
Lasso di tempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher humility.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Cognitive and Affective Mindfulness Scale-Revised (CAMS-R)
Lasso di tempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 4. Higher score indicates higher mindfulness.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Brief Self-Control Scale
Lasso di tempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher self-control

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Brief Resilience Scale
Lasso di tempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher resilience.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Loneliness: NIH Toolbox Adult Social Relationship Scales
Lasso di tempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher level of loneliness

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Transcendent Spirituality: subscale of Trait Sources of Spirituality Scale
Lasso di tempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher level of spirituality

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Persevering Hope Scale
Lasso di tempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher level of hope

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Coping Self-Efficacy Scale
Lasso di tempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 0 to 10. Higher score indicates higher level of self-efficacy

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
SDNN
Lasso di tempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Standard Deviation of Normal-to-Normal intervals, another HRV measure

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Mean Heart Rate
Lasso di tempo: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Mean Heart Rate

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 gennaio 2027

Completamento primario (Stimato)

1 agosto 2027

Completamento dello studio (Stimato)

1 dicembre 2027

Date di iscrizione allo studio

Primo inviato

15 novembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

15 novembre 2026

Primo Inserito (Effettivo)

20 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

20 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

15 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • Acta No. 005 de 2025

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi